The interleukin-17 pathway is involved in human alcoholic liver disease

Hepatology

Volumn 49, Issue 2, 2009, Pages 646-657

  Lemmers, Arnaud ^a,b   Moreno, Christophe ^a,b   Gustot, Thierry ^a,b   Maréchal, Raphäel ^a,b   Degré, Delphine ^a,b   Demetter, Pieter ^a   de Nadai, Patricia ^b   Geerts, Albert ^c   Quertinmont, Eric ^b   Vercruysse, Vincent ^b   Le Moine, Olivier ^a,b   Devière, Jacques ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GROWTH RELATED ONCOGEN ALPHA PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 8; MYELOPEROXIDASE; ONCOPROTEIN; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 17; UNCLASSIFIED DRUG; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL SECRETION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; LIVER BIOPSY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STELLATE CELL; T LYMPHOCYTE SUBPOPULATION; BLOOD; CYTOLOGY; ITO CELL; LIVER CIRRHOSIS; METABOLISM; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SECRETION;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; C-REACTIVE PROTEIN; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS C, CHRONIC; HEPATITIS, ALCOHOLIC; HUMANS; INTERLEUKIN-17; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; NEUTROPHILS; REFERENCE VALUES;

EID: 61949356502     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22680     Document Type: Article

References (52)

1. Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract 2007;4:24-34.
2. Mandayam S, Jamal M, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004;24:217-232.
3. Tome S, Lucey MR. Review article: Current management of alcoholic liver disease. Aliment Pharmacol Ther 2004;19:707-714.
4. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. HEPATOLOGY 1989;9:349-351.
5. Devie're J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. HEPATOLOGY 1990;11:628-634.
6. Devie're J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis: Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol 1989;7:221-225.
7. Sheron N, Brid G, Koskinas J, Portmann B, Ceska M, Lindley I, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. HEPATOLOGY 1993;18:41-46.
8. Thiele GM, Freeman TL, Klassen LW. Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 2004;24:273-287.
9. Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, et al. Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. HEPATOLOGY 2006;43:989-1000.
10. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med 2003;228:882-890.
11. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998;114:842-845.
12. Mathurin P. Corticosteroids for alcoholic hepatitis-what's next? J Hepatol 2005;43:526-533.
13. Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, et al. Cell-mediated hepatic injury in alcoholic liver disease. Gastroenterology 1993;105:254-266.
14. Hines IN, Wheeler MD. Recent advances in alcoholic liver disease III: role of the innate immune response in alcoholic hepatitis. Am J Physiol 2004; 287:G310-G314.
15. Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002;27:23-27.
16. Weaver CT, Harrington LE, Mangan PR, Gavrielli M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24:677-688.
17. Steinman L. A brief history of Th17, the first major revision in the Th1/ Th2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139-145.
18. Ouyang W, Kolls JK, Zheng Y. The biological functions of T Helper 17 cells effector cytokines in inflammation. Immunity 2008; 4:454-467.
19. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukin 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007;8:942-949.
20. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-957.
21. van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007;27:1-7.
22. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-476.
23. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
24. Carithers RL Jr, Herlong HF, Dielh AM, Shaw EW, Combes B, Fallon HJ, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: A randomized multicenter trial. Ann Intern Med 1989;110:685-690.
25. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
26. Heathcote EJ. Management of primary biliary cirrhosis. The AASLD practice guidelines. HEPATOLOGY 2000; 31:1005-1013.
27. Alcoholic liver disease: Morphological manifestations. Review by an international group. Lancet 1981;1:707-711.
28. Mezey E. Treatment of alcoholic liver disease. Semin Liver Dis 1993;13: 210-216.
29. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005;41:1313-1321.
30. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994;20:15-20.
31. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52: 65-70.
32. Lenarczyk AJ, Helsloot K, Farmer L, Peters A, Sturgess A, Kirkham B. Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Clin Exp Immunol 2000;122:41-48.
33. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies 2. N Engl J Med 1993;328:1828-1835.
34. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther 1995;66:387-412.
35. Caligiuri A, De Franco RS, Romanelli RG, Gentilini A, Meuci M, Failli P, et al. Antifibrogenic effects of canrenone, an aldosteronic drug, on human hepatic stellate cells. Gastroenterology 2003;124:504-520.
36. Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, et al. IL-17 stimulates intraperitoneal neutrophils infiltration through the release of GROα chemokines from mesothelial cells. J Immunol 2000;165:5814-5821.
37. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, et al. Cutting edge: Roles of toll-like receptor 4 and IL-23 in IL-17 expression in response to klebsiella pneumoniae infection. J Immunol 2003;170:4432-4436.
38. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007;51:1139-1147.
39. Amadi-Obi A, Yu CH, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al. Th17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711-718.
40. Santos-Perez JL, Diez-Ruis A, Luna-Casado L, Soto-Mas JA, Wachter H, Fuchs D, et al. T-cell activation, expression of adhesion molecules and response to ethanol in alcoholic cirrhosis. Immunol Lett 1996;50:179-183.
41. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. Monocyte activation in alcoholic liver disease. Alcohol 2002;27:53-61.
42. Mookerjee RP, Stabauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. HEPATOLOGY 2007;46: 831-840.
43. Ferreti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170:2106-2112.
44. Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: Correlation with disease severity. Gastroenterology 2007;132:687-697.
45. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-1476.
46. Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogen-α, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol 2002;26: 748-753.
47. Awane M, Andres PG, Li DJ, Reinecker HC. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β-induced chemokines promoter activation in intestinal epithelial cells. J Immunol 1999;162: 5337-5344.
48. Hartupee J, Liu C, Novotny M, Li X, Hamilton T. IL-17 enhances chemokines gene expression through mRNA stabilization. J Immunol 2007; 179:4135-4141.
49. Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y, et al. IL-17 stimulates inflammatory responses via NF-êB and MAP kinase pathway in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2002;282:G1035-G1044.
50. Granet C, Miossec P. Combination of the pro-inflammatory cytokines IL-1, TNF-α, and IL-17 lead to enhanced expression and additional recruitment of AP-1 family members, EGR-1 and NF-κB in osteoblast-like cells. Cytokine 2004;26:169-177.
51. McMullen MR, Pritchard MT, Wang Q, Millward CA, Croniger CM, Nagy LE. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 2005;128:2066-2076.
52. Kishore R, Hill JR, McMullen MR, Frenkel J, Nagy LE. ERK1/2 and Egr-1 contribute to increased TNF-αproduction in rat kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 2002; 282:G6-G15.